Investigation Launched by Pomerantz Law Firm Into Nyxoah S.A. Investors' Claims

Pomerantz Law Firm Investigates Claims Regarding Nyxoah S.A.

The legal landscape has become increasingly intricate for investors in Nyxoah S.A. (NASDAQ: NYXH) as Pomerantz LLP, a prominent law firm known for its commitment to investor rights, has announced an investigation into potential claims against the company. The inquiry centers around allegations that Nyxoah, along with certain officers and directors, may have engaged in activities constituting securities fraud or other illicit business practices.

This developing story gained traction on March 25, 2025, when Nyxoah issued a press release confirming that the U.S. Food and Drug Administration (FDA) has provided an Approvable Letter concerning the company's Pre-Market Approval (PMA) application for its innovative Genio® system. According to Nyxoah, this letter indicates that their application for marketing the device in the United States meets the regulatory requirements outlined in the Federal Food, Drug, and Cosmetic Act. However, the approval is still contingent upon the successful review of the manufacturing facilities and controls.

Following this announcement, analysts began revisiting their projections for Nyxoah's commercial launch of the Genio device. Unfortunately, the delayed approval news led to a notable decline in Nyxoah's stock price, which plummeted by $2.42 per share—equivalent to a significant drop of 21.36%—closing at $8.91 on March 26, 2025.

Investors undoubtedly feel the weight of uncertainty as they watch the events unfold. Pomerantz LLP is now encouraging shareholders who believe they have been wronged to reach out for further information. Any affected individuals are urged to contact Danielle Peyton at the firm directly via email or phone.

Pomerantz LLP, with a long-standing history in corporate, securities, and antitrust class litigation, has earned recognition for its fierce advocacy on behalf of investors. Founded by the late Abraham L. Pomerantz, often referred to as the dean of class action bar, the firm has pioneered securities class actions and remains dedicated to protecting the rights of victims engulfed in securities fraud, breaches of fiduciary duty, and corporate misconduct. In its over 85 years of existence, Pomerantz has secured numerous multimillion-dollar settlements for its clients.

As developments surrounding Nyxoah continue to evolve, those impacted are reminded of the complexities linked with stock trading and market fluctuations. Investors should remain vigilant and informed to safeguard their interests during this tumultuous period. For ongoing updates and more information about joining the class action, interested parties should refer to the resources provided by Pomerantz LLP.

For anyone looking to learn more about Pomerantz's historical achievements or its current legal pursuits, a wealth of information can be found on their official website, www.pomlaw.com.